 |
|
| Blog results | Results 1 - 10 of about 17,743 for proton pump inhibitor. (0.25 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Understanding Acid Reflux - http://understandingacidreflux.com/ Acid Reflux Heartburn Treatment and Remedies - http://acidrefluxheartburn.com/ Reflux1.com - Complete Source for Heartburn Relief - http://reflux1.com/ Acid Reflux Disease Diet - http://theacidrefluxdiet.blogspot.com/ | |
| 11 Nov 2009 11, 2009) — Despite being highly effective and beneficial for many patients, unexpected consequences are emerging in patients who are prescribed proton pump inhibitors (PPIs) for reflux diseases. Physicians are warned to monitor these ... BioSpace.com Featured News and Stories - http://www.biospace.com/ [ More results from BioSpace.com Featured News and Stories ] |
| 21 hours ago XenoPort announced it has initiated a Phase 2b clinical trial of arbaclofen placarbil, also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor ... Latest articles from MPR - http://www.empr.com/ |
| 2 Nov 2009 by ANI Washington, Nov 2 (ANI): Researchers have warned that despite being highly effective for many patients, unexpected consequences are emerging in. Trak.in News» Trak.in News | Business... - http://trak.in/news/ [ More results from Trak.in News» Trak.in News | Business... ] |
| 9 hours ago by AdPharm Esomeprazole is a proton pump inhibitor (brand names Sompraz, Zoleri, Nexium??, Lucen, Esopral; Axagon in Italy, Nexiam in Belgium) developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease ... AdPharm Blog - http://blog.adpharm.net/ [ More results from AdPharm Blog ] |
| 11 Nov 2009 by Scott Despite being highly effective and beneficial for many patients, unexpected consequences are emerging in patients who prescribed proton pump inhibitors reflux diseases. Physicians warned to monitor these effects prescribe medications. Ads News - http://www.adsnews.net/ |
| 1 Nov 2009 by SindhToday Washington, Nov 2 (ANI): Researchers have warned that despite being highly effective for many patients, unexpected consequences are emerging in patients who are prescribed proton pump inhibitors (PPIs) for reflux diseases. ... Sindh Today - Online News - http://www.sindhtoday.net/ |
| 22 Nov 2009 by Frank Singh said previous research has shown that adding a proton pump inhibitor to high-dose naproxen use cuts the risk of complications in half. For further study, he suggested evaluating whether that is also the case for low-dose patients. ... ChiroOrg Blog - For Chiropractic and Chiropract... - http://www.chiro.org/wordpress/ |
| 1 Nov 2009 by Kenneth W. Altman, James A. Radosevich Otolaryngology - Head and Neck Surgery, Volume 141, Issue 5, Pages 564-566, November 2009, Authors:Kenneth W. Altman; James A. Radosevich. Otolaryngology - Head and Neck Surgery - http://www.otojournal.org/?rss=yes [ More results from Otolaryngology - Head and Neck Surgery ] |
| 18 Nov 2009 by it ... healthcare providers to new safety information concerning an interaction between clopidogrel (Plavix®), an anticlotting medication, and omeprazole (Prilosec™/Prilosec OTC™), a proton pump inhibitor (PPI) used to reduce stomach acid. ... Hayes » Health Technology Assessment &... - http://www.hayesinc.com/hayes/ |
| 1 May 2005 by admin Currently, it is the best studied proton pump inhibitor for use during pregnancy. A reproductive study in rats and rabbits found no teratogenic effect in fetal development after administering doses up to 250-500 times greater than the ... ITIS - http://66.242.154.95/resources/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
